TMA-2
Discover related
4 sources
How the databases line up — = agree, ≈ partial, ≠ differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).
| PsychonautWiki | TripSit | Pharmacology | PiHKAL | ||
|---|---|---|---|---|---|
| Classification | |||||
| Class / category | — | — | ≈ | ||
| Also known as | TMA-2 | — | — | 2,4,5-TRIMETHOXYAMPHETAMINE | ≠ |
| Safety | |||||
| Addiction potential | not habit-forming | — | — | — | |
| Toxicity | toxic dose is unknown | — | — | — | |
| Dose · Oral | |||||
| Threshold | 5 mg | 5 mg | — | — | = |
| Light | 10–20 mg | 10–20 mg | — | — | = |
| Common | 20–40 mg | 20–40 mg | — | 20–40 mg | = |
| Strong | 40–60 mg | 40–60 mg | — | — | = |
| Heavy | 60 mg+ | — | — | — | |
| Duration | |||||
| Onset | 20–120 minutes | 20–120 minutes | — | — | = |
| Total | 8–12 hours | 6–12 hours | — | 8–12 hours | ≠ |
| After-effects | 4–24 hours | — | — | — | |
| Pharmacology | |||||
Dose at a glance
Each database's primary-route ladder on one shared scale — see where ranges line up or shift.
Duration at a glance
Total duration on one shared scale.
TripSit summary
Trimethoxyamphetamine-2, a psychedelic amphetamine and stimulant first synthesised by Alexander Shulgin. An uncommon compound of similar activity to other psychedelic amphetamines. Short history of human use.
PiHKAL summary
Simply relocating one methoxy group of TMA into a new arrangement unexpectedly boosted potency roughly tenfold, with clear activity around 20 to 24 milligrams. The discovery, which came with considerable first-time anxiety and psychosomatic difficulty, made this pattern a high-priority template and one of the essential amphetamines with natural botanical parallels.
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.